Dietary Omega-3 PUFAs in Metabolic Disease Research: A Decade of Omics-Enabled Insights (2014–2024)
Nutrients · 28.05.2025 · 17 (11) · 1836
DOI: 10.3390/nu17111836 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 28.05.2025. Verfasst von Jing Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, Metabolic Diseases, Diet. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Program, Warshel Institute for Computational Biology funding from Shenzhen City and Longgang District, Shenzhen-Hong Kong Cooperation Zone for Technology and Innovation.
Abstract (Originalsprache)
Background/Objectives: The rising global prevalence of metabolic diseases (e.g., obesity, type 2 diabetes mellitus) underscores the need for effective interventions. Omega-3 polyunsaturated fatty acids (PUFAs) exhibit therapeutic potential, yet their molecular mechanisms remain unclear. This systematic review synthesizes a decade (2014–2024) of omics research to elucidate Omega-3 PUFA mechanisms in metabolic diseases and identify future directions.
Methods
A PRISMA-guided search of the Web of Science identified studies on Omega-3 PUFAs, metabolic diseases, and omics. After excluding reviews, non-English articles, and irrelevant studies, 72 articles were analyzed (16 multi-omics, 17 lipidomics, 10 transcriptomics/metabolomics/microbiomics each, and 6 proteomics).
Results
Omics studies demonstrated that Omega-3 PUFAs, particularly EPA and DHA, improve metabolic health through interconnected mechanisms. They regulate epigenetic processes, including DNA methylation and miRNA expression, influencing genes linked to inflammation and insulin sensitivity. Omega-3 PUFAs reduce oxidative stress by mitigating protein carbonylation and enhancing antioxidant defenses. Gut microbiota modulation is evident through increased beneficial taxa (e.g., Bacteroidetes, Akkermansia) and reduced pro-inflammatory species, correlating with improved metabolic parameters. Mitochondrial function is enhanced via upregulated fatty acid oxidation and TCA cycle activity, while anti-inflammatory effects arise from NF-κB pathway suppression and macrophage polarization toward an M2 phenotype. Challenges include interindividual variability in responses and a limited understanding of dynamic metabolic interactions.
Conclusions
Omega-3 PUFAs target multiple pathways to improve metabolic health. Future research should prioritize chemoproteomics for direct target identification, multi-omics integration, and personalized strategies combining Omega-3 with therapies like calorie restriction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
- Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
- Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China.
- R&D Center, Better Way (Shanghai) Cosmetics Co., Ltd., Shanghai 201103, China.
- Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, Chin…
ORCID-Profile: Yang-Chi-Dung Lin, Hua-Li Zuo, Hsi-Yuan Huang, Tao Zhang
Förderung
- Shenzhen Science and Technology Program
- Warshel Institute for Computational Biology funding from Shenzhen City and Longgang District
- Shenzhen-Hong Kong Cooperation Zone for Technology and Innovation
- Guangdong Young Scholar Development Fund of Shenzhen Ganghong Group Co., Ltd.
- Phase III Government Matching Fund of Shenzhen Ganghong Group Co., Ltd.
- Guangdong S&T programme
- 2023 The Second Affiliated Hospital of the Chinese University of Hong Kong, Shenzhen Joint Fund Project
- CUHK(SZ) HOMEY HEALTH Micro-biome and EndoMetabolic Digital Health Research Center
Zitieren
APA
Li, J., Lin, Y. C., Zuo, H. L., Huang, H. Y., Zhang, T., Bai, J. W., & Huang, H. D. (2025). Dietary Omega-3 PUFAs in Metabolic Disease Research: A Decade of Omics-Enabled Insights (2014–2024). Nutrients, 17(11), 1836. https://doi.org/10.3390/nu17111836
Vancouver
Li J, Lin YC, Zuo HL, Huang HY, Zhang T, Bai JW, et al. Dietary Omega-3 PUFAs in Metabolic Disease Research: A Decade of Omics-Enabled Insights (2014–2024). Nutrients. 2025;17(11):1836. doi:10.3390/nu17111836
BibTeX
@article{Li2025,
author = {Li, Jing and Lin, Yang-Chi-Dung and Zuo, Hua-Li and Huang, Hsi-Yuan and Zhang, Tao and Bai, Jin-Wei and Huang, Hsien-Da},
title = {Dietary Omega-3 PUFAs in Metabolic Disease Research: A Decade of Omics-Enabled Insights (2014–2024)},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {11},
pages = {1836},
doi = {10.3390/nu17111836}
}
EUVIMED